3 Lingering Questions About How Actavis Works
District courts have been wrestling with more than a dozen cases challenging so-called pay-for-delay deals since the U.S. Supreme Court ruled that the pharmaceutical patent settlements could be scrutinized under antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article